# Blueprint Medicines Corporation (BPMC): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/bpmc for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific blood disorders, specifically those identified by genomic markers. These efforts extend to patients both within the United States and across international markets. The company's robust pipeline includes several key therapies. AYVAKIT is being advanced for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors. They are also developing BLU-263, a potent, orally administe...

## Quote & Key Metrics

As of 2025-07-18:

| Metric | Value |
|---|---|
| Price | $129.46 USD |
| Market Cap | $8.36B |
| P/E (TTM) | -51.58 |
| EPS (TTM) | −$2.51 |
| 52-Week Range | $73.04 – $129.55 |
| Dividend Yield (TTM) | — |

## Dividend

BPMC has no dividend payment history in our records.

## Frequently Asked Questions

### What does Blueprint Medicines Corporation do?

Blueprint Medicines Corporation (BPMC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is BPMC's market cap?

Blueprint Medicines Corporation (BPMC) has a market capitalization of approximately $8.36 billion, as of July 18, 2025, based on the most recent share price and shares outstanding.

### Does BPMC pay a dividend?

No, Blueprint Medicines Corporation (BPMC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is BPMC profitable?

Blueprint Medicines Corporation (BPMC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has BPMC ever paid a dividend?

No. Dividend Data's records show no dividend payments from Blueprint Medicines Corporation (BPMC). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/bpmc
- Dividend history & safety: https://www.dividenddata.com/stocks/bpmc/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/bpmc/earnings
- Financial statements: https://www.dividenddata.com/stocks/bpmc/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/bpmc/valuation
- Peer comparison: https://www.dividenddata.com/stocks/bpmc/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.